bradykinin, leu(8)-des-arg(9)- and atenolol

bradykinin, leu(8)-des-arg(9)- has been researched along with atenolol in 2 studies

Compound Research Comparison

Studies (bradykinin, leu(8)-des-arg(9)-)	Trials (bradykinin, leu(8)-des-arg(9)-)	Recent Studies (post-2010) (bradykinin, leu(8)-des-arg(9)-)	Studies (atenolol)	Trials (atenolol)	Recent Studies (post-2010) (atenolol)
102	0	7	5,473	1,950	852

Protein Interaction Comparison

Protein	Taxonomy	atenolol (IC50)
Beta-1 adrenergic receptor	Homo sapiens (human)	0.7468
Alpha-1D adrenergic receptor	Homo sapiens (human)	0.23
Alpha-1A adrenergic receptor	Homo sapiens (human)	0.23
Alpha-1B adrenergic receptor	Homo sapiens (human)	0.23

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (50.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cunha, FQ; Cunha, JM; Ferreira, SH; Lorenzetti, BB; Poole, S	1
Chichorro, JG; Lorenzetti, BB; Zampronio, AR	1

Other Studies

2 other study(ies) available for bradykinin, leu(8)-des-arg(9)- and atenolol

Article	Year
Bradykinin B1 and B2 receptors, tumour necrosis factor alpha and inflammatory hyperalgesia. British journal of pharmacology, 1999, Volume: 126, Issue:3 Topics: Adrenergic beta-Antagonists; Animals; Atenolol; Bradykinin; Bradykinin Receptor Antagonists; Carrageenan; Dinoprostone; Dose-Response Relationship, Drug; Drug Synergism; Hyperalgesia; Indomethacin; Inflammation; Interleukin-8; Kallidin; Lipopolysaccharides; Male; Mice; Pain Measurement; Pain Threshold; Rats; Rats, Wistar; Receptor, Bradykinin B1; Receptor, Bradykinin B2; Receptors, Bradykinin; Sheep; Time Factors; Tumor Necrosis Factor-alpha	1999
Involvement of bradykinin, cytokines, sympathetic amines and prostaglandins in formalin-induced orofacial nociception in rats. British journal of pharmacology, 2004, Volume: 141, Issue:7 Topics: Animals; Arachidonic Acids; Atenolol; Behavior, Animal; Biogenic Amines; Bradykinin; Bradykinin B1 Receptor Antagonists; Bradykinin B2 Receptor Antagonists; Captopril; Celecoxib; Cytokines; Dose-Response Relationship, Drug; Drug Synergism; Facial Pain; Formaldehyde; Guanethidine; Hindlimb; Indomethacin; Injections, Subcutaneous; Interleukin-6; Interleukin-8; Lip; Male; Meloxicam; Nociceptors; Prostaglandins; Pyrazoles; Rats; Rats, Wistar; Receptor, Bradykinin B1; Receptor, Bradykinin B2; Sulfonamides; Thiazines; Thiazoles; Tumor Necrosis Factor-alpha; Tyramine	2004

Article

Year

Bradykinin B1 and B2 receptors, tumour necrosis factor alpha and inflammatory hyperalgesia.

British journal of pharmacology, 1999, Volume: 126, Issue:3

Topics: Adrenergic beta-Antagonists; Animals; Atenolol; Bradykinin; Bradykinin Receptor Antagonists; Carrageenan; Dinoprostone; Dose-Response Relationship, Drug; Drug Synergism; Hyperalgesia; Indomethacin; Inflammation; Interleukin-8; Kallidin; Lipopolysaccharides; Male; Mice; Pain Measurement; Pain Threshold; Rats; Rats, Wistar; Receptor, Bradykinin B1; Receptor, Bradykinin B2; Receptors, Bradykinin; Sheep; Time Factors; Tumor Necrosis Factor-alpha

1999

Involvement of bradykinin, cytokines, sympathetic amines and prostaglandins in formalin-induced orofacial nociception in rats.

British journal of pharmacology, 2004, Volume: 141, Issue:7

Topics: Animals; Arachidonic Acids; Atenolol; Behavior, Animal; Biogenic Amines; Bradykinin; Bradykinin B1 Receptor Antagonists; Bradykinin B2 Receptor Antagonists; Captopril; Celecoxib; Cytokines; Dose-Response Relationship, Drug; Drug Synergism; Facial Pain; Formaldehyde; Guanethidine; Hindlimb; Indomethacin; Injections, Subcutaneous; Interleukin-6; Interleukin-8; Lip; Male; Meloxicam; Nociceptors; Prostaglandins; Pyrazoles; Rats; Rats, Wistar; Receptor, Bradykinin B1; Receptor, Bradykinin B2; Sulfonamides; Thiazines; Thiazoles; Tumor Necrosis Factor-alpha; Tyramine

2004